๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes

โœ Scribed by Yang, S. J.; Min, K. W.; Gupta, S. K.; Park, J. Y.; Shivane, V. K.; Pitale, S. U.; Agarwal, P. K.; Sosale, A.; Gandhi, P.; Dharmalingam, M.; Mohan, V.; Mahesh, U.; Kim, D. M.; Kim, Y. S.; Kim, J. A.; Kim, P. K.; Baik, S. H.


Book ID
118227715
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
600 KB
Volume
15
Category
Article
ISSN
1462-8902

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES